Journal For Clinical Studies
Journal For Clinical Studies

SEARCH

MEDIA PACK
NEWS

MENU

Current Edition

 
anxiety

RLS bags $10M to trial dry powder inhaled CBD in anxiety

Investors have bought into Receptor Life Sciences’ vision of treating acute anxiety disorders using a dry powder inhaled cannabidiol (CBD). With $9.7 million in fresh …

13 April 2022 Regional News anxiety CBD
Continue Reading →
 
jcs-white

Journal for Clinical Studies

Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.

Facebook Twitter Linkedin
Journal For Clinical Studies © 2022, All Rights Reserved – Powered by Teksyte